Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Colorectal Neoplasms

  Free Subscription


Articles published in Oncology

Retrieve available abstracts of 28 articles:
HTML format
Text format



Single Articles


    August 2019
  1. OGIMI T, Sadahiro S, Kamei Y, Chan LF, et al
    Distribution of Neuroendocrine Marker-Positive Cells in Colorectal Cancer Tissue and Normal Mucosal Tissue: Consideration of Histogenesis of Neuroendocrine Cancer.
    Oncology. 2019 Aug 7:1-7. doi: 10.1159/000501521.
    PubMed     Text format     Abstract available


    June 2019
  2. CHOI HH, Cho YS, Choi JH, Kim HK, et al
    Stool-Based miR-92a and miR-144* as Noninvasive Biomarkers for Colorectal Cancer Screening.
    Oncology. 2019 Jun 19:1-7. doi: 10.1159/000500639.
    PubMed     Text format     Abstract available


    April 2019
  3. LARSEN FO, Jensen BV, Norgaard HH, Hermann HK, et al
    Intrahepatic Oxaliplatin and Systemic 5-FU +/- Cetuximab in Chemo-Naive Patients with Liver Metastases from Colorectal Cancer.
    Oncology. 2019 Apr 18. pii: 000499314. doi: 10.1159/000499314.
    PubMed     Text format     Abstract available


    March 2019
  4. TAMPAKIS A, Tampaki EC, Nonni A, Droeser R, et al
    Nectin-1 Expression in Colorectal Cancer: Is There a Group of Patients with High Risk for Early Disease Recurrence?
    Oncology. 2019 Mar 27:1-8. doi: 10.1159/000499569.
    PubMed     Text format     Abstract available


    February 2019
  5. KOBAYASHI K, Kawakami K, Yokokawa T, Aoyama T, et al
    Association of Hand-Foot Skin Reaction with Regorafenib Efficacy in the Treatment of Metastatic Colorectal Cancer.
    Oncology. 2019 Feb 14:1-7. doi: 10.1159/000495989.
    PubMed     Text format     Abstract available


    January 2019
  6. SHIRATORI H, Kawai K, Hata K, Tanaka T, et al
    Correlations between the Recurrence Patterns and Sizes of Lateral Pelvic Lymph Nodes before and after Chemoradiotherapy in Patients with Lower Rectal Cancer.
    Oncology. 2019;96:33-43.
    PubMed     Text format     Abstract available


  7. YAMAMOTO A, Toiyama Y, Okugawa Y, Saigusa S, et al
    Identification of Predictors of Recurrence in Patients with Lower Rectal Cancer Undergoing Neoadjuvant Chemotherapy: A Direct Comparison of Short-Course and Long-Course Chemoradiotherapy.
    Oncology. 2019;96:70-78.
    PubMed     Text format     Abstract available


    December 2018
  8. CHEN KH, Lin LI, Tseng LH, Lin YL, et al
    CpG Island Methylator Phenotype May Predict Poor Overall Survival of Patients with Stage IV Colorectal Cancer.
    Oncology. 2018 Dec 12:1-8. doi: 10.1159/000493387.
    PubMed     Text format     Abstract available


    October 2018
  9. HAYASHI K, Mitani S, Taniguchi H, Yasui H, et al
    Panitumumab Provides Better Survival Outcomes Compared to Cetuximab for Metastatic Colorectal Cancer Patients Treated with Prior Bevacizumab within 6 Months.
    Oncology. 2018 Oct 25:1-8. doi: 10.1159/000493321.
    PubMed     Text format     Abstract available


    August 2018
  10. WILLIS D, Samalin E, Satge D
    Colorectal Cancer in People with Intellectual Disabilities.
    Oncology. 2018 Aug 31:1-14. doi: 10.1159/000492077.
    PubMed     Text format     Abstract available


  11. OKADA K, Sadahiro S, Chan LF, Ogimi T, et al
    The Number of Natural Killer Cells in the Largest Diameter Lymph Nodes Is Associated with the Number of Retrieved Lymph Nodes and Lymph Node Size, and Is an Independent Prognostic Factor in Patients with Stage II Colon Cancer.
    Oncology. 2018 Aug 23:1-9. doi: 10.1159/000491019.
    PubMed     Text format     Abstract available


  12. SANTASUSAGNA S, Moreno I, Navarro A, Martinez Rodenas F, et al
    Prognostic Impact of miR-200 Family Members in Plasma and Exosomes from Tumor-Draining versus Peripheral Veins of Colon Cancer Patients.
    Oncology. 2018 Aug 23:1-10. doi: 10.1159/000490726.
    PubMed     Text format     Abstract available


  13. ITO N, Kawahira H, Nakashima H, Uesato M, et al
    Endoscopic Diagnostic Support System for cT1b Colorectal Cancer Using Deep Learning.
    Oncology. 2018 Aug 21:1-7. doi: 10.1159/000491636.
    PubMed     Text format     Abstract available


    July 2018
  14. SEKINE K, Hamaguchi T, Shoji H, Takashima A, et al
    Retrospective Analyses of Systemic Chemotherapy and Cytoreductive Surgery for Patients with Ovarian Metastases from Colorectal Cancer: A Single-Center Experience.
    Oncology. 2018 Jul 20:1-9. doi: 10.1159/000489665.
    PubMed     Text format     Abstract available


    March 2018
  15. TANIOKA H, Miyamoto Y, Tsuji A, Asayama M, et al
    Prophylactic Effect of Dexamethasone on Regorafenib-Related Fatigue and/or Malaise: A Randomized, Placebo-Controlled, Double-Blind Clinical Study in Patients with Unresectable Metastatic Colorectal Cancer (KSCC1402/HGCSG1402).
    Oncology. 2018 Mar 7. pii: 000486624. doi: 10.1159/000486624.
    PubMed     Text format     Abstract available


    January 2018
  16. PETRELLI F, Ardito R, Ghidini A, Zaniboni A, et al
    Different Toxicity of Cetuximab and Panitumumab in Metastatic Colorectal Cancer Treatment: A Systematic Review and Meta-Analysis.
    Oncology. 2018 Jan 23. pii: 000486338. doi: 10.1159/000486338.
    PubMed     Text format     Abstract available


  17. SAITO G, Sadahiro S, Ogimi T, Miyakita H, et al
    Relations of Changes in Serum Carcinoembryonic Antigen Levels before and after Neoadjuvant Chemoradiotherapy and after Surgery to Histologic Response and Outcomes in Patients with Locally Advanced Rectal Cancer.
    Oncology. 2018;94:167-175.
    PubMed     Text format     Abstract available


  18. DE FELICE F, Martinetti MT, Orelli S, Bulzonetti N, et al
    Definitive Chemoradiotherapy for Anal Carcinoma: Long-Term Results Based on Consistent Time-to-Event Endpoints.
    Oncology. 2018;94:25-30.
    PubMed     Text format     Abstract available


  19. HASS HG, Vogel U, Scheurlen M, Jobst J, et al
    Use of Gene Expression Analysis for Discrimination of Primary and Secondary Adenocarcinoma of the Liver.
    Oncology. 2018;95:211-219.
    PubMed     Text format     Abstract available


  20. SUZUKI T, Sadahiro S, Tanaka A, Okada K, et al
    Outcomes of Local Excision plus Chemoradiotherapy in Patients with T1 Rectal Cancer.
    Oncology. 2018;95:246-250.
    PubMed     Text format     Abstract available


  21. TOIYAMA Y, Oki S, Okugawa Y, Ide S, et al
    Clinical Impact of Preoperative Albumin-Globulin Ratio in Patients with Rectal Cancer Treated with Preoperative Chemoradiotherapy.
    Oncology. 2018;95:270-280.
    PubMed     Text format     Abstract available


    January 2017
  22. DELHORME JB, Severac F, Waissi W, Romain B, et al
    Surgery Is an Effective Option after Failure of Chemoradiation in Cancers of the Anal Canal and Anal Margin.
    Oncology. 2017;93:183-190.
    PubMed     Text format     Abstract available


  23. YAMADA M, Sakurai T, Komeda Y, Nagai T, et al
    Clinical Significance of Bmi1 Expression in Inflammatory Bowel Disease.
    Oncology. 2017;93 Suppl 1:20-26.
    PubMed     Text format     Abstract available


  24. OGAWA S, Ishii T, Minaga K, Nakatani Y, et al
    The Feasibility of 18-mm-Diameter Colonic Stents for Obstructive Colorectal Cancers.
    Oncology. 2017;93 Suppl 1:43-48.
    PubMed     Text format     Abstract available


  25. SAKURAI T, Adachi T, Kono M, Arizumi T, et al
    Prophylactic Suturing Closure Is Recommended after Endoscopic Treatment of Colorectal Tumors in Patients with Antiplatelet/Anticoagulant Therapy.
    Oncology. 2017;93 Suppl 1:27-29.
    PubMed     Text format     Abstract available


  26. KOMEDA Y, Kashida H, Sakurai T, Asakuma Y, et al
    Magnifying Narrow Band Imaging (NBI) for the Diagnosis of Localized Colorectal Lesions Using the Japan NBI Expert Team (JNET) Classification.
    Oncology. 2017;93 Suppl 1:49-54.
    PubMed     Text format     Abstract available


  27. OKAMOTO K, Watanabe T, Komeda Y, Kono T, et al
    Risk Factors for Postoperative Bleeding in Endoscopic Submucosal Dissection of Colorectal Tumors.
    Oncology. 2017;93 Suppl 1:35-42.
    PubMed     Text format     Abstract available


  28. SUZUKI T, Sadahiro S, Tanaka A, Okada K, et al
    A Modified Classification of Prognostic Factors Based on Pathological Stage and Tumor Regression Grade in Patients with Rectal Cancer Who Receive Preoperative Chemoradiotherapy.
    Oncology. 2017;93:287-294.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: